#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis Duchenne muscular dystrophy gene carrier Vulval cancer recurrent Glomerulonephritis chronic Fabry's disease Ovarian cancer stage III Malignant peritoneal neoplasm Squamous cell carcinoma of the cervix Primary adrenal insufficiency Ewing's sarcoma recurrent Bronchopulmonary dysplasia Urethral valves Ventricular fibrillation Waldenstrom's macroglobulinaemia refractory Carcinoid tumour More trials…

    Learn about Rare Diseases

    Pemphigus – Treatment Rett syndrome – Trials in Disease Atypical haemolytic uraemic syndrome – Trials in Disease Hereditary ataxia Mantle cell lymphoma stage II – Diagnostics Lymphangiosarcoma Marginal zone lymphoma refractory – Life with Disease Systemic sclerosis pulmonary Basal cell naevus syndrome – Basic Information Advanced systemic mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ulipristal Acetate Tafamidis Quercetin UDONITRECTAG Pbf-999 Dorzolamide Hydrochloride Bisoprolol Nafarelin Molgramostim Follitropin Alfa YL201 Specific Nucleic Acid Sna-Veru Human Coagulation Factor Ix RO7795081 Pegipanermin Arachis Hypogaea Flour Neflamapimod Cemiplimab RP2 IHMA-2121908-1 More therapies…

    Learn about Your Condition

    Vulval cancer Cerebral haemorrhage Hypomagnesaemia Chondrosarcoma Congenital pseudarthrosis Brain injury Endometrial cancer stage II Choroidal dystrophy Sickle cell disease External cephalic version Chronic kidney disease Mantle cell lymphoma stage II Leiomyosarcoma metastatic Hernia repair Heparin resistance More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast neoplasm

  • Study of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Goserelin Acetate
    • Ly3484356
    • Tamoxifen Citrate
    Belgium France Germany Italy

  • Study on the Effects of Selumetinib, Bicalutamide, and Olaparib in Patients with Metastatic Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Bicalutamide
    • Selumetinib
    • Olaparib
    Italy

  • Study of oral TherO2-01S22 with anti-HER2 therapy in patients with metastatic breast cancer

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Vinorelbine Tartrate
    • Trastuzumab
    • Pertuzumab
    France

  • Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Fulvestrant
    • Abemaciclib
    Belgium Czechia Denmark France Greece Hungary +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!